Fundraising Fox
Fusmobile
Founded 2014 · 22 employees on LinkedIn · 2 known investors
Find your way into Fusmobile
Sign up to see every warm intro you have to Fusmobile
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fusmobile team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
FUS Mobile develops the Neurolyser XR, a non-invasive medical device that uses high intensity focused ultrasound (HIFU) with fluoroscopic guidance to thermally ablate the lumbar medial branch nerve for treating chronic facet-mediated low back pain. It is intended for interventional pain management physicians and is approved in Europe and has US De Novo marketing authorization.
Investors · 2
Frequently asked questions
- What does Fusmobile do?
- FUS Mobile develops the Neurolyser XR, a non-invasive medical device that uses high intensity focused ultrasound (HIFU) with fluoroscopic guidance to thermally ablate the lumbar medial branch nerve for treating chronic facet-mediated low back pain. It is intended for interventional pain management physicians and is approved in Europe and has US De Novo marketing authorization.
- Who are Fusmobile's investors?
- Fusmobile's investors include Atlanta Technology Angels, OrbiMed.